MISTR Hits Major Milestone Marker, Surpasses Half a Million Patients

The Telehealth Company Solidifies its Impact as a Leader Across Sexual Healthcare and an Advocate for the LGBTQ+ Community

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--MISTR, the largest telemedicine provider offering free online STI testing, PrEP, DoxyPEP, and long-term HIV care in all 50 states, D.C., and Puerto Rico, has reached its most significant growth milestone yet, serving over 500 thousand patients nationwide. This accomplishment underscores the company’s commitment to delivering accessible HIV/STI prevention and treatment to historically underserved communities at zero cost.

This comes at a time when STI rates remain a persistent public health concern, with over 2.4 million cases of syphilis, gonorrhea, and chlamydia diagnosed and reported in 2023. Since the introduction of DoxyPEP to the general public in 2022, providers across the country have reported up to 50% decreases in bacterial STI diagnoses. Aside from MISTR’s flagship offering of HIV prevention & long-term HIV care, the introduction of DoxyPEP demand has skyrocketed, with over 74 percent of MISTR’s patients requesting the medication since launching in April of 2024. Prior to offering DoxyPEP, the STI positivity rate among MISTR patients was 12.42 percent, which has now dropped to 6.16 percent. This significant decrease emphasizes MISTR’s pivotal role in improving sexual health across the U.S.

“This milestone is a testament to the dedicated work that my team and our community have made towards stopping the spread of HIV and promoting safe sex practices,” said Tristan Schukraft, Founder and CEO of MISTR. “As a member of the LGBTQ+ community myself, this cause has always remained close to my heart. I’d like to think that MISTR is on a mission to safeguard the health of present and future generations.”

This landmark achievement comes on the heels of MISTR’s strategic partnership with Walmart stores in Georgia. The providers collaborated to offer free test kits at seven locations to combat the growing prevalence of HIV/STIs diagnoses in the state. MISTR aims to amplify its impact in 2025 by forging new partnerships and leveraging its storefront locations in West Hollywood, New York City, San Francisco, Chicago, Dallas, and Wilton Manors.

ABOUT MISTR:

MISTR is the largest telemedicine platform offering free online access to pre-exposure prophylaxis (PrEP) and long-term HIV care in all 50 states, D.C. and Puerto Rico. Gay owned and operated, MISTR has brought together a network of the best doctors, pharmacists, and problem solvers to make PrEP, DoxyPEP and long-term HIV care available to all who need it. No doctor’s office, no paperwork and free delivery. Visit www.mistr.com.